Emerging Technologies
Luxsonic's virtual reality suite, the SieVRt, landed clearance from Health Canada in order to be used in diagnostic radiology.
The online tool provides a COVID-19 patient's risk score, expected time to death and survival probability curve based on 15 health variables.
The new tool must be prescribed by a doctor, but is not intended to replace medications.
It measures brainwaves in real-time and uses machine learning to interpret them.
The wearable market is expected to reach $487 billion in revenue this year, according to the report.
The new system lets clinicians record and share videos – and communicate during an operation.
The Danish consumer platform helps users track skin changes.
It also announced its collaboration with an unnamed liquid biopsy company.
The new service will cost users $15 if the prescription is renewed.
The game is expected to roll out in early 2022 and in the winter of 2021 for members.